Spain to conduct clinical trials of Johnson & Johnson COVID-19 vaccine
Image Credit: Shortpedia
Alberto Borobia, the chief of the clinical trials unit of the La Paz University Hospital in Madrid has said that Spain is going to conduct the clinical trials of a vaccine developed by US corporation Johnson & Johnson starting Monday. 190 volunteers are expected to take part in the Phase 2 trials starting from Monday in Spain. The vaccine candidate's phase 1 trials were held in the United States and Belgium.